Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schellekens

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of Virology|August 1, 1992
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domainJ D Laman, M M Schellekens, Y H Abacioglu, et al.
Journal of Lipid Research|February 1, 1992
Immunological discrimination between the human apolipoprotein E2(Arg158----Cys) and E3 isoformsK Gerritse, P de Knijff, G van Ierssel, et al.
Journal of Virology|March 1, 1992
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domainJ D Laman, M M Schellekens, Y H Abacioglu, et al.
Critical Care (London, England)|April 20, 2016
Strategies to optimize respiratory muscle function in ICU patientsWillem-Jan M Schellekens, Hieronymus W H van Hees, Jonne Doorduin, et al.
AIDS Research and Human Retroviruses|July 1, 1993
A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibodyJ D Laman, M M Schellekens, G K Lewis, et al.
European Journal of Immunology|September 5, 2002
Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12)Jon D Laman, Bert A 't Hart, Herbert Brok, et al.
Open Forum Infectious Diseases|February 12, 2026
Ophthalmologic Evaluation and Clinical Outcome in Candidemia: A 7-Year Retrospective Multicenter Cohort StudyHanne Lamberink, Shantelle A E Ortega, Isa M Schellekens, et al.
Vaccine|October 31, 2003
Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigensCatharina B M Maassen, Jon D Laman, Conny van Holten-Neelen, et al.
Journal of Neuroimmunology|August 30, 2001
Novel monoclonal antibodies against proteolipid protein peptide 139-151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesionsJ D Laman, L Visser, C B Maassen, et al.
Annals of Surgery|May 20, 2017
SM22 a Plasma Biomarker for Human Transmural Intestinal IschemiaDirk H S M Schellekens, Kostan W Reisinger, Kaatje Lenaerts, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Virology|August 1, 1992
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domainJ D Laman, M M Schellekens, Y H Abacioglu, et al.
Journal of Lipid Research|February 1, 1992
Immunological discrimination between the human apolipoprotein E2(Arg158----Cys) and E3 isoformsK Gerritse, P de Knijff, G van Ierssel, et al.
Journal of Virology|March 1, 1992
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domainJ D Laman, M M Schellekens, Y H Abacioglu, et al.
Critical Care (London, England)|April 20, 2016
Strategies to optimize respiratory muscle function in ICU patientsWillem-Jan M Schellekens, Hieronymus W H van Hees, Jonne Doorduin, et al.
AIDS Research and Human Retroviruses|July 1, 1993
A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibodyJ D Laman, M M Schellekens, G K Lewis, et al.
European Journal of Immunology|September 5, 2002
Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12)Jon D Laman, Bert A 't Hart, Herbert Brok, et al.
Open Forum Infectious Diseases|February 12, 2026
Ophthalmologic Evaluation and Clinical Outcome in Candidemia: A 7-Year Retrospective Multicenter Cohort StudyHanne Lamberink, Shantelle A E Ortega, Isa M Schellekens, et al.
Vaccine|October 31, 2003
Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigensCatharina B M Maassen, Jon D Laman, Conny van Holten-Neelen, et al.
Journal of Neuroimmunology|August 30, 2001
Novel monoclonal antibodies against proteolipid protein peptide 139-151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesionsJ D Laman, L Visser, C B Maassen, et al.
Annals of Surgery|May 20, 2017
SM22 a Plasma Biomarker for Human Transmural Intestinal IschemiaDirk H S M Schellekens, Kostan W Reisinger, Kaatje Lenaerts, et al.
Pageof 7